GALD — Galderma AG Cashflow Statement
0.000.00%
Last trade - 00:00- CH₣32.55bn
- CH₣34.43bn
- $4.44bn
Annual cashflow statement for Galderma AG, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -156 | -98.5 | -57.2 | 231 |
| Depreciation | ||||
| Amortisation | ||||
| Non-Cash Items | 428 | 423 | 594 | 477 |
| Unusual Items | ||||
| Equity in Net Earnings/Losses | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -329 | -491 | -648 | -513 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Net Change in Other Assets & Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 196 | 111 | 165 | 488 |
| Capital Expenditures | -128 | -160 | -153 | -275 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -395 | 93 | -20.9 | -51 |
| Sale of Fixed Assets | ||||
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -523 | -66.5 | -174 | -326 |
| Financing Cash Flow Items | -10.7 | -7.3 | 0 | -33 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 307 | -79.4 | 142 | -58 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -37.1 | -59.5 | 134 | 90 |